BIOHAVEN PHARMACTL HLDG CO L's ticker is BHVN and the CUSIP is G11196105. A total of 309 filers reported holding BIOHAVEN PHARMACTL HLDG CO L in Q1 2022. The put-call ratio across all filers is 0.75 and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $65,715,000 | +8732.7% | 434,703 | +8423.6% | 3.09% | +9867.7% |
| Q2 2022 | $744,000 | -82.6% | 5,100 | -85.9% | 0.03% | -80.0% |
| Q1 2022 | $4,279,000 | -33.7% | 36,100 | -22.9% | 0.16% | -32.3% |
| Q4 2021 | $6,450,000 | -3.9% | 46,800 | -3.1% | 0.23% | -19.6% |
| Q3 2021 | $6,709,000 | +48.3% | 48,300 | -8.5% | 0.28% | +63.8% |
| Q4 2020 | $4,525,000 | +29.2% | 52,800 | +10.2% | 0.17% | -12.1% |
| Q2 2020 | $3,502,000 | +183.6% | 47,900 | +32.0% | 0.20% | +104.1% |
| Q1 2020 | $1,235,000 | – | 36,281 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 490,422 | $12,755,876 | 13.24% |
| FNY Investment Advisers, LLC | 30 | $0 | 0.00% |